NEW YORK (GenomeWeb News) – The Massachusetts General Hospital Cancer Center plans to begin using gene-based tests for nearly all of its cancer patients to help make treatment decisions as part of a personalized healthcare initiative, it said this week.

The hospital said it will use its newly opened translational research laboratory to support this program, which also is aimed at gathering research data from tumors that may contribute to more personalized treatments in the future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.